Cargando…

Defining the role of corticotropin releasing factor binding protein in alcohol consumption

The corticotropin releasing factor (CRF) exerts its effects by acting on its receptors and on the binding protein (CRFBP), and has been implicated in alcohol use disorder (AUD). Therefore, identification of the exact contribution of each protein that mediates CRF effects is necessary to design effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haass-Koffler, C L, Henry, A T, Melkus, G, Simms, J A, Naemmuddin, M, Nielsen, C K, Lasek, A W, Magill, M, Schwandt, M L, Momenan, R, Hodgkinson, C A, Bartlett, S E, Swift, R M, Bonci, A, Leggio, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314120/ https://www.ncbi.nlm.nih.gov/pubmed/27845775 http://dx.doi.org/10.1038/tp.2016.208

Ejemplares similares

Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity
por: Haass-Koffler, Carolina L., et al.
Publicado: (2012)

Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving
por: Haass-Koffler, C L, et al.
Publicado: (2015)

Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein
por: Haass-Koffler, Carolina L., et al.
Publicado: (2022)

Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research
por: Curley, Dallece E., et al.
Publicado: (2021)

Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters
por: Haass-Koffler, Carolina L., et al.
Publicado: (2017)

Serum Insulin Levels Are Reduced by Intravenous Ghrelin Administration but Do Not Correlate with Alcohol Craving in Alcohol-Dependent Individuals
por: Haass-Koffler, Carolina L., et al.
Publicado: (2016)

The α5 Subunit Regulates the Expression and Function of α4*-Containing Neuronal Nicotinic Acetylcholine Receptors in the Ventral-Tegmental Area
por: Chatterjee, Susmita, et al.
Publicado: (2013)

Bacchus by Caravaggio as the Visual Diagnosis of Alcohol Use Disorder from the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
por: Haass-Koffler, Carolina L., et al.
Publicado: (2013)

The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
por: Suchankova, P, et al.
Publicado: (2015)

Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use
por: Farokhnia, Mehdi, et al.
Publicado: (2022)

Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic
por: Brown, Zoe E., et al.
Publicado: (2021)

A Relationship between the aldosterone - mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans
por: Aoun, E.G., et al.
Publicado: (2017)

CORTICOTROPINS (ACTH) : X. BIOLOGICAL INVESTIGATIONS ONα-CORTICOTROPIN
por: Li, Choh Hao, et al.
Publicado: (1957)

The hypothalamic–pituitary–adrenal axis in critical illness: responses to the low-dose corticotropin (ACTH) stimulation test and human corticotropin-releasing hormone (hCRH)
por: Alevizopoulou, P, et al.
Publicado: (2004)

Knockdown of corticotropin-releasing factor in the central amygdala reverses persistent viscerosomatic hyperalgesia
por: Johnson, A C, et al.
Publicado: (2015)

Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long–Evans rats
por: Richards, Jemma K., et al.
Publicado: (2008)

Leptin Gene and Leptin Receptor Gene Polymorphisms in Alcohol Use Disorder: Findings Related to Psychopathology
por: Browning, Brittney D., et al.
Publicado: (2021)

Pregnancy anxiety, placental corticotropin-releasing hormone and length of gestation
por: Ramos, Isabel F., et al.
Publicado: (2022)

Molecular, Morphological, and Functional Characterization of Corticotropin-Releasing Factor Receptor 1-Expressing Neurons in the Central Nucleus of the Amygdala
por: Wolfe, S. A., et al.
Publicado: (2019)

Diagnostic Accuracy of Dehydroepiandrosterone Sulfate and Corticotropin in Autonomous Cortisol Secretion
por: Carafone, Lindsay E., et al.
Publicado: (2021)

Corticotropin-Releasing Factor: An Ancient Peptide Family Related to the Secretin Peptide Superfamily
por: Michalec, Ola M., et al.
Publicado: (2020)

Colocalization of connexin 36 and corticotropin-releasing hormone in the mouse brain
por: Westberg, Lars, et al.
Publicado: (2009)

Is there any place to corticotropin test in sepsis?
por: Abdellatif, S, et al.
Publicado: (2004)

The upside of stress: a mechanism for the positive motivational role of corticotropin releasing factor
por: Lemos, Julia C., et al.
Publicado: (2019)

Endocrinology and the brain: corticotropin-releasing hormone signaling
por: Inda, Carolina, et al.
Publicado: (2017)

Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport
por: Le, Michelle H., et al.
Publicado: (2016)

Reproducibility of the low-dose corticotropin (ACTH) stimulation test in ICU patients with sepsis and/or septic shock
por: Dimopoulou, I, et al.
Publicado: (2006)

Corticotropin-releasing factor neurons in the bed nucleus of the stria terminalis exhibit sex-specific pain encoding in mice
por: Yu, Waylin, et al.
Publicado: (2021)

Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep
por: Kimura, M, et al.
Publicado: (2009)

Altered maternal profiles in corticotropin-releasing factor receptor 1 deficient mice
por: Gammie, Stephen C, et al.
Publicado: (2007)

Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers
por: Vatsalya, Vatsalya, et al.
Publicado: (2015)

On the role of corticotropin-releasing hormone receptors in anxiety and depression
por: Reul, Johannes M. H. M., et al.
Publicado: (2002)

Energy metabolism and behavior in the corticotropin-releasing factor family of peptides
por: Carr, James A., et al.
Publicado: (2015)

An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
por: J Gingell, Joseph, et al.
Publicado: (2016)

An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
por: Gingell, Joseph J, et al.
Publicado: (2016)

Adrenal function in protracted critical illness: evaluation with the low-dose (1 μg) corticotropin stimulation test
por: Dimopoulou, I, et al.
Publicado: (2002)

Corticotropin-Releasing Hormone (CRH) Gene Family Duplications in Lampreys Correlate With Two Early Vertebrate Genome Doublings
por: Cardoso, João C. R., et al.
Publicado: (2020)

Amygdalar Corticotropin-Releasing Factor Signaling Is Required for Later-Life Behavioral Dysfunction Following Neonatal Pain
por: Davis, Seth M., et al.
Publicado: (2021)

The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration
por: Srinivasan, Subhashini, et al.
Publicado: (2012)

Cortisol reserve in head trauma victims: evaluation with the low-dose (1 μg) corticotropin (ACTH) stimulation test
por: Dimopoulou, I, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_qj0lgsb4tn8lsaana42brhl484